• Skip to main content
  • Skip to primary sidebar
  • Home
  • News
  • Education
  • Events
  • Interviews
    • Career spotlight
  • Opinion
    • Professional Dilemmas
    • Patient perspective
  • PIPcast
  • Jobs
  • Business Directory

Pharmacy in Practice

EDX/20/1154
Date of prep: December 2020

Prescribing information and
adverse events reporting

For healthcare professionals only

Global pharmacy data and intelligence commission launched

28th September 2020 by PIP editor Leave a Comment

 

The One FIP Data and Intelligence Commission was launched during FIP Virtual 2020. The commission will provide strategic advice on the development of the Global Pharmaceutical Observatory (GPO).

 

The FIP GPO builds on FIP’s foundational history of collating and using pharmacy-related data and will be a global data hub that can be used to inform advocacy work for FIP members and partners. It will aid policy development, decision-making, workforce intelligence, and the advancement of pharmaceutical practice, health and life sciences, education and skills training.

 

Incorporating the FIP Development Goals launched earlier this week, the FIP GPO will deliver an expansive set of validated information to drive evidence-based analysis of past, current and future trends.

 

Members of the commission, chaired by Professor Robert Sindelar, University of British Columbia, Canada, will provide assurance and guidance on achieving the FIP GPO vision and mission, which were presented at FIP Virtual 2020 today. They will also validate the integration of GPO activities across FIP and with stakeholders, and advocate for the FIP GPO. Members of the commission will be drawn from across FIP’s boards, sections, regions and member organisations, and a nomination process will be circulated in due course.

 

Professor Sindelar said:

 

“Data volumes will continue to increase and experts agree that the amount of generated data will be growing exponentially every day into the future. The key is not just collecting data and individual observations, but turning that data into intelligence that empowers FIP and its stakeholders to form a predictive picture that enables better decision-making for pharmacy and the pharmaceutical sciences.”

 

Related

Next article  GPhC say assessment is an 'essential step' towards registration

Filed Under: News Tagged With: FIP, FIPcongress

Register for our upcoming webinar and live Q&A

About PIP editor

Pharmacy in Practice is a UK pharmacy publication with its roots in Scotland.

Reader Interactions

Begin the discussion right here Cancel reply

Primary Sidebar

Categories

PIP business directory

Letters to the editor

Letters to the editor

Is a pharmacist who sells rapid antibody tests unfit to practise?

It is difficult to know how to ask a patient if they can read

Pharmacies should be allowed to supply rapid antibody tests

‘PRN’ medicines like Tramadol should never be on repeat

More letters to the editor here...

Blogs

💊 PIP live pharmacy blog

Winter stresses must not ‘destabilise’ general practice

What is it like to depend on medicine to treat endometriosis?

Opinion

Why is pharmacy not integral to government mass vaccination plans?

Pharmacy Covid-19 vaccination involvement is a ‘no-brainer’

The great patient medication returns debacle

CPD Challenges

💊 CPD Challenge: How well do you understand pulmonary embolisms?

💊 CPD Challenge: Prescribing and dispensing clozapine

💊 CPD Challenge: Oral anticoagulants – Dabigatran

More CPD challenges here...

© 2021 · About Pharmacy In Practice · Site mantained by Mike

This site is for healthcare professionals, please confirm you are a healthcare professional to continue.

YES

Pharmacy In Practice uses cookies, by continuing to use this site we will assume you are ok with that Find out more.